Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-15 Sale | 2024-07-16 6:00 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 39,600 | $45.53 | $1,803,143 | 164,381 (Direct) | View |
| 2024-03-04 Sale | 2024-03-04 6:21 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 3,344 | $41.86 | $139,967 | 241,990 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 4:34 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 400 | $45 | $18,000 | 137,192 (Direct) | View |
| 2024-02-09 Sale | 2024-02-09 7:47 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 46,137 | $35.5 | $1,638,071 | 137,592 (Direct) | View |
| 2023-03-02 Sale | 2023-03-03 4:30 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 1,298 | $31 | $40,233 | 187,209 (Direct) | View |
| 2021-11-01 Sale | 2021-11-02 6:45 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 57,493 | $62.16 | $3,573,658 | 317,284 (Direct) | View |
| 2021-03-11 Sale | 2021-03-15 9:12 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 15,000 | $60.13 | $901,991 | 170,361 (Direct) | View |
| 2021-02-22 Sale | 2021-02-24 6:44 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 37,064 | $50.68 | $1,878,355 | 47,547 (Direct) | View |
| 2021-02-17 Sale | 2021-02-19 7:27 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 22,936 | $56.42 | $1,293,936 | 84,611 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-15 Exercise | 2024-07-16 6:00 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 39,600 | $0 | 164,381 (Direct) | View |
| 2024-07-15 Exercise | 2024-07-16 6:00 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 39,600 | $2.08 | 164,381 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 6:21 pm | N/A 2034-02-28 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 170,625 | $0 | 241,990 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 4:34 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 400 | $0 | 137,192 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 4:34 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 400 | $2.08 | 137,192 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-09 7:47 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 46,137 | $0 | 137,592 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-09 7:47 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 46,137 | $2.08 | 137,592 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:30 pm | N/A 2033-02-28 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 131,250 | $0 | 187,209 (Direct) | View |
| 2022-05-04 Exercise | 2022-05-04 09:02 am | N/A 2028-10-31 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 20,000 | $0 | 196,076 (Direct) | View |
| 2022-05-04 Exercise | 2022-05-04 09:02 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 9,792 | $2.08 | 196,076 (Direct) | View |
| 2022-05-04 Exercise | 2022-05-04 09:02 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 10,208 | $1.31 | 196,076 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:30 pm | N/A 2032-02-29 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 88,400 | $0 | 113,057 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-02 6:45 pm | N/A 2028-10-31 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 39,603 | $0 | 317,284 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-02 6:45 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 19,603 | $2.08 | 317,284 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-02 6:45 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 20,000 | $1.31 | 317,284 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-15 9:12 pm | N/A 2028-10-31 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 10,000 | $0 | 170,361 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-15 9:12 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 10,000 | $1.31 | 170,361 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:57 pm | N/A 2031-02-28 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:31 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 48,942 | $0 | 48,942 (Direct) | View |
Ownership | 2020-08-20 8:34 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 0 | $0 | 399,359 (Direct) | View |